Other languages Solid Biosciences Inc.

Equities

SLDB

US83422E2046

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-01 EDT			5-day change	1st Jan Change
9.54 ^USD	+7.55%		+8.78%	+55.37%

04-01	Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label	MT
04-01	Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label	04-01
Solid Biosciences Inc. Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003	04-01
Solid Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-13
Solid Biosciences Inc. Announces Licensing Agreement with Armatus Bio for the Use of Aav-Slb101, A Proprietary, Muscle-Targeted Capsid, in the Development of an Rnai Therapy to Treat Fshd	03-07
Solid Biosciences Gets FDA Orphan Drug Designation for Duchenne Drug Candidate	01-16
Top Midday Gainers	01-09
Solid Biosciences Shares Surge After Revealing $109 Million Private Placement	01-09
Solid Biosciences Shares Fall After Surging Thursday; HC Wainwright Starts Coverage With Buy Rating	12-08
Sector Update: Health Care Stocks Retreating Late Afternoon	12-07
Top Midday Gainers	12-07
Solid Biosciences Says FDA Grants Fast Track Designation to Duchenne Muscular Dystrophy Gene Therapy; Shares Rise	12-07
Wall Street opnieuw hoger gesloten	11-15
Wall Street weet openingswinsten vast te houden	11-15
Wall Street op weg naar hogere start	11-15
Wall Street Set to Extend Rally on Back of Cooling Inflation, Driving Premarket Gains for US Equity Futures	11-15
Inflation, Retail Data Eyed as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Wednesday	11-15
Top Premarket Gainers	11-15
Futures wijzen verder omhoog	11-15
Solid Biosciences New Drug Application for Duchenne Muscular Dystrophy Gets FDA Clearance; Shares Soar Premarket	11-15
MORNING BRIEFING - USA/Asien	11-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Solid Biosciences Inc.

Equities

SLDB

US83422E2046

Other languages

Filters